Concepedia

Ruth Hunegnaw

RH

Statistics

Publications

17

Citations

579

H-Index

13

Active since

2010

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Center for Cancer Research

The University of Texas Medical Branch at Galveston

Ruth Hunegnaw is an author at National Institutes of Health specializing in infectious diseases, vaccinology, and viral infections.

ORCID

Publications per year

2010–2023

17

Publications

17

An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge

Alec W. Freyn, Caroline Atyeo, Patricia L. Earl et al. · Science Translational Medicine · 2023 · 97 citations

, , +17

Nuclear cysteine cathepsin variants in thyroid carcinoma cells

Sofia Tedelind, Kseniia Poliakova, Amanda Valeta et al. · Biological Chemistry · 2010 · 71 citations · Full text

, , +15

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

Melinda Hamer, Katherine V. Houser, Amelia R. Hofstetter et al. · The Lancet · 2023 · 65 citations · Full text

, , +16

An introduction to the Marburg virus vaccine consortium, MARVAC

Robert W. Cross, Ira M. Longini, Stephan Becker et al. · PLoS Pathogens · 2022 · 54 citations · Full text

, , +13

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates

Ruth Hunegnaw, Anna N. Honko, Lingshu Wang et al. · Science Translational Medicine · 2022 · 42 citations

, , +17

1–5 of 17